Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00100711 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

Interventions

DRUG: Motexafin Gadolinium

Sponsor

Pharmacyclics LLC.